Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 4 |
2020 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Repurposing the yellow fever vaccine for intratumoral immunotherapy.
EMBO Mol Med. 2020 Jan 9;12(1):e10375. doi: 10.15252/emmm.201910375. Epub 2019 Nov 19.
EMBO Mol Med. 2020.
PMID: 31746149
Free PMC article.
The DNA damage response acts as a safeguard against harmful DNA-RNA hybrids of different origins.
Barroso S, Herrera-Moyano E, Muñoz S, García-Rubio M, Gómez-González B, Aguilera A.
Barroso S, et al.
EMBO Rep. 2019 Sep;20(9):e47250. doi: 10.15252/embr.201847250. Epub 2019 Jul 24.
EMBO Rep. 2019.
PMID: 31338941
Free PMC article.
Item in Clipboard
Notch and EGFR regulate apoptosis in progenitor cells to ensure gut homeostasis in Drosophila.
Reiff T, Antonello ZA, Ballesta-Illán E, Mira L, Sala S, Navarro M, Martinez LM, Dominguez M.
Reiff T, et al.
EMBO J. 2019 Oct 4;38(21):e101346. doi: 10.15252/embj.2018101346. Epub 2019 Sep 30.
EMBO J. 2019.
PMID: 31566767
Free PMC article.
Item in Clipboard
Systemic CD4 immunity: A powerful clinical biomarker for PD-L1/PD-1 immunotherapy.
Zuazo M, Arasanz H, Bocanegra A, Chocarro L, Vera R, Escors D, Kagamu H, Kochan G.
Zuazo M, et al.
EMBO Mol Med. 2020 Sep 7;12(9):e12706. doi: 10.15252/emmm.202012706. Epub 2020 Jul 10.
EMBO Mol Med. 2020.
PMID: 32648370
Free PMC article.
Item in Clipboard
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies.
Gandullo-Sánchez L, Capone E, Ocaña A, Iacobelli S, Sala G, Pandiella A.
Gandullo-Sánchez L, et al.
EMBO Mol Med. 2020 May 8;12(5):e11498. doi: 10.15252/emmm.201911498. Epub 2020 Apr 24.
EMBO Mol Med. 2020.
PMID: 32329582
Free PMC article.
Item in Clipboard
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.
Zuazo M, Arasanz H, Fernández-Hinojal G, García-Granda MJ, Gato M, Bocanegra A, Martínez M, Hernández B, Teijeira L, Morilla I, Lecumberri MJ, Fernández de Lascoiti A, Vera R, Kochan G, Escors D.
Zuazo M, et al.
EMBO Mol Med. 2019 Jul;11(7):e10293. doi: 10.15252/emmm.201910293. Epub 2019 Jun 6.
EMBO Mol Med. 2019.
PMID: 31273938
Free PMC article.
Item in Clipboard
Cite
Cite